Testing a glucose-monitoring device in septic shock ICU
Part of Heart & circulation, Hormones & metabolism, Infections clinical trials.
This trial checks whether a continuous glucose monitoring system (“CGM GUARDIAN 2”) can be used safely and effectively for people in the ICU who have septic shock and high blood sugar. It may help the medical team track blood sugar more easily while you receive insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the ICU with septic shock (a serious infection affecting the whole body).
- Your blood pressure is low and you need noradrenaline to keep it up.
- Your blood sugar is high enough that you are being treated with insulin.
- You are not pregnant and not breastfeeding.
- You are able to consent (not under legal protection such as guardianship/curatorship, and not deprived of liberty).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This trial tests if using a continuous glucose monitor (CGM) after leaving the hospital helps manage diabetes. You wear a small sensor on your arm that checks your sugar levels all day and sends them to your phone.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
Hear when a new Hyperglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.